Merck tops earnings expectations, thanks to strong cancer-drug sales
July 30, 2019 at 09:30 AM EDT
Pharmaceutical giant Merck & Co. Inc. blew away earnings expectations in the second quarter, thanks to soaring sales of its blockbuster cancer drug Keytruda.